Form 4: Merit Medical COO Neil Peterson's Equity Transactions

Merit Medical Systems COO Neil Peterson reported recent equity transactions, including RSU and PSU grants, and tax-related share dispositions.

Summary

• Neil W. Peterson, Chief Operating Officer of Merit Medical Systems Inc. (MMSI), reported changes in his beneficial ownership.
• On February 26, 2026, Peterson was granted 7,690 Restricted Stock Units (RSUs) which are scheduled to vest in three equal annual installments on the first three anniversaries of the grant date.
• On the same date, he acquired 17,002 shares of common stock upon the satisfaction of conditions for previously granted Performance Stock Units (PSUs) from February 28, 2023.
• Peterson surrendered 6,061 shares of common stock to the Issuer at a price of $78.02 per share to cover payroll and income taxes, with no shares sold in the open market.
• Following these transactions, Peterson directly owns 47,000 shares of common stock.
• He also holds non-qualified stock options for 25,000 shares (exercisable at $68.33, expiring 08/19/2028) and 13,576 shares (exercisable at $70.58, expiring 02/28/2030).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as slightly positive, reflecting routine executive compensation activities including new equity grants and the successful vesting of performance-based awards, which aligns executive incentives with company performance.

Positives

• The grant of 7,690 Restricted Stock Units (RSUs) indicates ongoing incentive and retention for a key executive.
• The acquisition of 17,002 shares from Performance Stock Units (PSUs) suggests that performance conditions set by the Compensation and Talent Development Committee were met, reflecting positive company performance against set metrics.

Negatives

• The disposition of 6,061 shares for tax purposes, while a common practice upon vesting, reduces the executive's direct shareholding.

Risks

• The Power of Attorney explicitly states that it does not relieve the undersigned from responsibility for compliance with Section 13 or Section 16 of the Exchange Act, including reporting requirements and potential disgorgement of profits under Section 16(b).

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider equity grants and vesting, such as those reported by Merit Medical's COO, are common practices across the medical device industry to align executive incentives with shareholder value and retain key talent. The tax-related disposition is a standard procedure for covering tax obligations upon vesting.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) for executive compensation is a standard practice in the medical technology sector, similar to companies like Medtronic or Boston Scientific, aiming to align executive incentives with long-term company performance and shareholder returns.
• The disposition of shares for tax withholding upon vesting of equity awards is a routine event for executives across all industries, including healthcare, and does not indicate a sale in the open market.

Corporate Governance

Stakeholder Impact

• Shareholders: The grants of RSUs and vesting of PSUs align executive incentives with shareholder interests, potentially encouraging long-term value creation.
• Employees: Reflects standard executive compensation practices, which can influence overall compensation philosophy within the company.

Next Steps

• RSUs granted on 02/26/2026 will vest in three equal annual installments on the first three anniversaries of the grant date.
• Non-qualified stock options granted on 08/19/2022 will continue to vest in equal annual installments of 25% until fully exercisable.
• Non-qualified stock options granted on 02/28/2024 will continue to vest in equal annual installments of 25% until fully exercisable.

Key Dates

Recommendation

This Form 4 details routine executive compensation events, including equity grants and tax-related share dispositions, which do not provide new fundamental information to warrant a change in investment thesis. The transactions are expected and align executive incentives, supporting a 'hold' recommendation.

Keywords

Merit Medical Systems, MMSI, Insider Trading, Form 4, Stock Options, Restricted Stock Units, Performance Stock Units, Executive Compensation, Neil W. Peterson, Chief Operating Officer